Overview

Fast Facts

• The Boston Scientific Cardiac Surgery business launched the first endoscopic vessel harvesting (EVH) system in 1997 and was the first to receive a radial artery indication for EVH (May 2003). As of 2006, more than 650,000 EVH procedures have been performed. Today we are the market leader in EVH.

• EVH provides improved outcomes (reduced wound complications) and high patient satisfaction¹.

• Boston Scientific’s line of Clampless Beating Heart products help surgeons provide optimal outcomes for high-risk CABG patients².

• In November 2005, the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) published the Beating Heart Consensus Statement that cited beating heart surgery offers distinct benefits over conventional bypass surgery, especially among high-risk patient populations.

• The Boston Scientific XPose® Access Device was the first heart-positioner.

• The Boston Scientific Ultima OPCAB™ System was the first heart stablilizer.

• Our FLEXview™ System is the first unilateral access platform for ablation.

• Boston Scientific cardiac surgery products are backed by our industry leading training and support organization.

¹ Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothroacic Surgery 2005. Innovations. 2005; 1:51-60
² Puskas J, Cheng D, Knight J, et al. Off-pump versus conventional coronary artery bypass grafting: a meta-analysis and consensus statement from the 2004 ISMICS Consensus Conference. Innovations. 2005;1:3-27.